TRAW icon

Traws Pharma
TRAW

Overview Fund Activity

27 hedge funds and large institutions have $18.1M invested in Traws Pharma in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
+10
Holders Change %
+58.82%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
7
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
6CM
1
683 Capital Management
New York
$5.87M
2
TCP
2
Tyndall Capital Partners
New York
$4.95M
3
EC
3
EcoR1 Capital
California
$3.03M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$1.46M
5
KC
5
Kepos Capital
New York
$1.21M

Top Sellers

1
SM
1
Sabby Management
Florida
$26K
2
Millennium Management
2
Millennium Management
New York
$0
3
PAM
3
Panagora Asset Management
Massachusetts
$5K
4
HFM
4
Hartford Financial Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
HFM
26
Hartford Financial Management
Connecticut
– – -1,252 Closed
Barclays
27
Barclays
United Kingdom
– – -60 Closed
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 30 -1 -3%
Citigroup
29
Citigroup
New York
$0 100 – –
BlackRock
30
BlackRock
New York
$0 652 – –
1
2